Clinical trial
Evaluation of Safety and Efficacy of the BTL-785F Device for Non-invasive Facial Rejuvenation in Patients Injected With Botulinum Toxin
NCT05524766 is registered in ClinicalTrials.gov with BTL Industries Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety and Efficacy of the BTL-785F Device for Non-invasive Facial Rejuvenation in Patients Injected With Botulinum Toxin
- Lead sponsor
- BTL Industries Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 6, 2022
- Completion date
- February 8, 2023
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
wrinkle